To investigate the mechanism of the role of SLC2A3 on malignant biological behaviors, 340 oral cancer patients from TCGA were categorized into high and low SLC2A3 expression cohorts based on median expression levels. This evidence concerns the gene SLC2A3 and lip and oral cavity carcinoma.